Table 4.
Total number of fetuses with external anomalies (%).
| No of fetuses with external anomalies (%) | Control | Imatinib low dose (6th–13th) | Imatinib low dose (13th–19th) | Imatinib high dose (6th–13th) | Imatinib high dose (13th–19th) |
|---|---|---|---|---|---|
| Harelip | 0 | 0 | 0 | 15 (38.46) | 6 (14.29) |
| Exencephaly | 0 | 0 | 0 | 10 (25.64) | 4 (9.52) |
| Encephalocoele | 0 | 0 | 0 | 4 (10.26) | 3 (7.14) |
| Paralysis of the hind limb | 0 | 2 (4.88) | 3 (4.41) | 2 (5.13) | 1 (2.38) |
| Contraction of the fore limb | 0 | 3 (7.32) | 3 (4.41) | 3 (7.69) | 1(2.38) |
| Congestion | 0 | 2 (4.88) | 4 (5.88) | 3 (7.69) | 2 (4.76) |
| Subcutaneous hemorrhage | 0 | 0 | 1(1.47) | 7 (17.95) | 5 (11.90) |
| Hematoma | 0 | 0 | 0 | 3 (7.69) | 0 |